Dr. Francesco Raimondi received his masters degree in industrial biotechnology from the University of Modena in 2006 and his PhD in chemistry from the same university in 2010 in Professor Fanelli's group. Dr. Raimondi has almost 10 years of experience in the computational structural biology field, where he developed and applied molecular modelling, simulation and drug discovery protocols to target bio-molecular systems related to cancer and neurological diseases. His major efforts have focused on G protein-coupled receptors and GTPase signaling pathways. More recently, in collaboration with Dr. Gloeckner's group at the DZNE, he participated in the first effort to model the quaternary (fourth order) structure of LRRK2 by integrating various low resolution structural data. Since January 2015, Dr. Raimondi has worked in Professor Russell's group at the University of Heidelberg, where he analyses the impact of missense variants (mutations) and post-translational modifications (changes) on protein function in natural and pathological conditions through innovative structural bioinformatic approaches.